Gene · 3078
Papers1,634
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,634
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A bibliometric analysis of complement in IgA nephropathy from 1991 to 2022. | Front Pharmacol | 2023 | 37576817 | PubTator, text mining | PubMed |
| A highly sensitive nanochannel device for the detection of SUMO1 peptides. | Chem Sci | 2023 | 37564410 | PubTator, text mining | PubMed |
| Atypical Hemolytic-Uremic Syndrome: Genetic Basis, Clinical Manifestations, and a Multidisciplinary Approach to Management. | J Multidiscip Healthc | 2023 | 37560408 | PubTator, text mining | PubMed |
| Eculizumab discontinuation in a patient with atypical hemolytic uremic syndrome after ChAdOx1 nCoV-19 vaccination. | Clin Nephrol Case Stud | 2023 | 37485074 | PubTator, text mining | PubMed |
| Ultrasensitive Electrochemiluminescence Immunosensor for Bladder Marker Human Complement Factor H-Related Protein Detection. | Anal Chem | 2023 | 37478154 | PubTator, text mining | PubMed |
| Genotypic analysis of a large cohort of patients with suspected atypical hemolytic uremic syndrome. | J Mol Med (Berl) | 2023 | 37466676 | PubTator, text mining | PubMed |
| Clinical utility of genetic testing in Indian children with kidney diseases. | BMC Nephrol | 2023 | 37464296 | PubTator, text mining | PubMed |
| A computational approach for the identification of key genes and biological pathways of chronic lung diseases: a systems biology approach. | BMC Med Genomics | 2023 | 37422662 | PubTator, text mining | PubMed |
| FOXO3 regulates Smad3 and Smad7 through SPON1 circular RNA to inhibit idiopathic pulmonary fibrosis. | Int J Biol Sci | 2023 | 37416778 | PubTator, text mining | PubMed |
| Characterization of large-scale genomic differences in the first complete human genome. | Genome Biol | 2023 | 37403156 | PubTator, text mining | PubMed |
| Ischemic cerebrovascular complications with initial presentation of genetic atypical hemolytic uremic syndrome. | J Stroke Cerebrovasc Dis | 2023 | 37392483 | PubTator, text mining | PubMed |
| Reshaping the Concept of Riedel's Thyroiditis into the Larger Frame of IgG4-Related Disease (Spectrum of IgG4-Related Thyroid Disease). | Biomedicines | 2023 | 37371786 | PubTator, text mining | PubMed |
Analysis of Plasma Proteins Involved in Inflammation, Immune Response/Complement System, and Blood Coagulation upon Admission of COVID-19 Patients to Hospital May Help to Predict the Prognosis of the Disease. | Cells | 2023 | 37371071 | PubTator, text mining | PubMed |
| Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study. | Blood | 2023 | 37369098 | PubTator, text mining | PubMed |
| Heme Interactions as Regulators of the Alternative Pathway Complement Responses and Implications for Heme-Associated Pathologies. | Curr Issues Mol Biol | 2023 | 37367079 | PubTator, text mining | PubMed |
| A 78-Year-Old Man with Chronic Kidney Disease and Monoclonal Gammopathy Who Developed Post-Transplant C3 Glomerulopathy - Recurrence or De Novo? A Case Report and Literature Review. | Am J Case Rep | 2023 | 37329130 | PubTator, text mining | PubMed |
| A single-center experience of post-transplant atypical hemolytic uremic syndrome. | Clin Nephrol | 2023 | 37288831 | PubTator, text mining | PubMed |
| Elevated plasma complement factor H related 5 protein is associated with venous thromboembolism. | Nat Commun | 2023 | 37286573 | PubTator, text mining | PubMed |
| Human umbilical cord mesenchymal stem cell-derived exosomes ameliorate liver steatosis by promoting fatty acid oxidation and reducing fatty acid synthesis. | JHEP Rep | 2023 | 37274776 | PubTator, text mining | PubMed |
| Anti-fibrotic effect of ciglitazone in HRV-induced airway remodelling cell model. | J Cell Mol Med | 2023 | 37259630 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3078/papers?page=8